STUDY QUESTION: Does the time from ovum pick-up (OPU) to frozen embryo transfer (FET) affect reproductive outcomes in a freezeall strategy?
Introduction
Since the development of IVF, the use of gonadotropins therapy for ovarian stimulation and the retrieval of multiple oocytes has become central to infertility treatment and, together with the optimization of laboratory techniques, has led to increasingly greater success rates (Barnhart, 2014) . Unfortunately, controlled ovarian hyperstimulation (COH) appears to exert a detrimental effect on endometrial receptivity (Shapiro et al., 2011) .
Recruitment and development of multiple follicles lead to supraphysiological oestrogen concentrations in blood, and premature progesterone elevations during COH, which affect the gene expression pattern of the normal, cyclic endometrium (Check et al., 1999; Horcajadas et al., 2005; Simon et al., 2005; Horcajadas et al., 2008; Haouzi et al., 2009; Venetis et al., 2013; Roque et al., 2015; Venetis et al., 2015) . These alterations translate into an advanced endometrial receptive phase and an embryoendometrium asynchrony, which in turn can have detrimental effects on the implantation of a healthy embryo (Ubaldi et al., 1997; Kolibianakis et al., 2002; Zapantis et al., 2013; Rodriguez-Purata et al., 2016) . There is also evidence that superovulation alters the immune environment of the endometrium, with a significant increase of endometrial natural killer cells in oocyte donors during stimulated cycles, compared with natural cycles (Junovich et al., 2011; Chaouat, 2013) . It has been shown that these effects of COH have a negative impact on implantation rates (IRs) in fresh transfers compared with frozen embryo transfer (FET) (Shapiro et al., 2011; Roque et al., 2013; Shapiro et al., 2013) ; further, epidemiologic studies indicate that the peri-implantation environment following COH may be contributing to some of the adverse perinatal outcomes associated with pregnancies after fresh embryo transfer (ET), an effect that can be minimized by freezing all embryos and transferring them in a subsequent FET cycle (Pelkonen et al., 2010; Kato et al., 2012; Maheshwari et al., 2012; Liu et al., 2013; Pelkonen et al., 2014; Ozgur et al., 2015) . The apparent better outcomes after elective FET in the context of a freeze-all strategy may be at least partially attributed to the lack of endometrial impairment that is observed during a stimulated cycle, and delaying ET may lead to a better synchrony between embryo development and the endometrial window of implantation (Horcajadas et al., 2008; Li et al., 2011) resulting in better placentation, as evidenced by studies in murine models (Kim et al., 2013) .
Although the detrimental effect of superovulation on reproductive and perinatal outcomes seems clear, no studies suggest how long it takes for the endometrial gene expression pattern and immune environment to return to their pre-stimulation functionality. Traditionally, elective FET has been performed 1-2 months after oocyte retrieval (Shapiro et al., 2015) . Delaying ET electively may add to the stress and anxiety accompanying a standard IVF cycle. So, although current evidence suggests that an elective FET may yield better reproductive outcomes when compared to fresh ET, data regarding the optimal time interval between ovum pick-up (OPU) and elective FET are lacking. In this context, we sought to identify whether endometrial receptivity is still impaired after the first withdrawal bleeding after OPU, and if performing FET during this first cycle or delaying FET to subsequent cycles has an impact on pregnancy and live birth rates (LBRs).
Materials and Methods
This retrospective cohort study includes patients between January 2012 and December 2014 who underwent an autologous IVF cycle where all available embryos were cryopreserved electively for future FET. Since this is a retrospective analysis of anonymized data managed as a cohort; it therefore does not require the approval of an ethical committee for clinical investigation under Spanish law (Orden SAS/3470/2009).
Study population
Premenopausal women aged between 20 and 45 years were included and all participants had a normal karyotype, since in our centre, it is a routine practice to screen for aneuploidy. Exclusion criteria were: BMI over 30 kg/m 2 ; presence of endocrine pathologies or uterine abnormalities; presence of chronic, autoimmune or metabolic diseases; need for testicular sperm extraction; evidence of meiotic chromosomal abnormalities in testicular biopsy or altered disomy or diploidy percentages in sperm fluorescence in situ hybridization, and participation within the previous 6 months, in a clinical trial with medication.
A freeze-all approach was proposed by the physicians based on three indications: prevention of ovarian hyperstimulation syndrome (OHSS), unfavourable endometrium (endometrial thickness <7 mm) and/or a midlate secretory pattern, homogeneous, hyperechoic functionalis extending from the basalis to the lumen, as described by Grunfeld et al. (1991) or the desire to optimize cycle outcomes. A total of 512 consecutive ET cycles met the inclusion criteria; we analysed the results of the first FET of the best available embryos between those which took place within the first menstrual cycle following OPU and those performed afterwards.
All patients underwent COH with exogenous gonadotrophins using two possible protocols: a flexible GnRH antagonist protocol, in which gonadotropins were started on the second day of cycle, introducing the antagonist when a follicle reached 14 mm in diameter, or a long GnRH agonist protocol, in which the agonist was started in the mid luteal phase of the preceding menstrual cycle, adding gonadotropins on the second day after menstrual bleeding.
Ovulation was triggered when follicles reached >17 mm in diameter, using either 0. Micronized progesterone (600 mg/day) was administered vaginally for luteal phase support (Utrogestan ® , SEID, Spain). The luteal phase was supported during the whole first trimester prior to April 2015. From then on, the duration was restricted to 9-10 weeks of gestational age (Giorlandino et al., 2015) .
Statistical analysis
The primary outcome of this study was the LBR. Secondary endpoints were IR [dichotomized to ≥50% vs <50%], pregnancy rate (PR), clinical pregnancy rate (CPR) and pregnancy loss (PL). All calculations were made on a 'per embryo transfer' basis.
IR is defined as the number of embryos transferred that develop to the stage of ultrasound documented gestational sac, divided by the number of transferred embryos, calculated for each woman. Clinical pregnancy is defined as the presence of an intrauterine gestational sac with embryonic cardiac activity, evaluated by ultrasound at 7 weeks of gestation. PL is defined as the loss of a pregnancy before 20 completed weeks of gestation. LBR is the number of live birth deliveries per FET.
Data analysis was performed using the IBM SPSS Statistics 20 (SPSS Inc., Chicago, IL) software. Comparison of quantitative variables was performed using Student's t, while categorical variables were compared using a Chi-square analysis. Differences were considered significant if two-tailed P-values were <0.05.
A multivariable logistic regression analysis was performed to determine the variables that could be independently associated with pregnancy, live birth or PL, and could affect outcomes. Maternal age (categorized to <35 years, 35-40 years and ≥40 years, to account for non-linear relationships), number of retrieved oocytes, number of transferred embryos (2-3 vs 1), day of embryonic development at transfer (+4 vs +3), drug used for ovulatory trigger (agonists vs hCG), reason for cryopreserving (OHSS, unfavourable endometrium or the desire to optimize outcomes), endometrial preparation used (transdermal vs oral oestrogen) and menstrual cycle following OPU (Cycle 1 vs Cycle ≥2) were included in the analysis.
Results
We analysed the results of the first FET of 512 cycles, comparing between those which took place within the first menstrual cycle following OPU (Cycle 1; 263 cycles) and those performed afterwards (Cycle ≥2; 249 cycles). The overall age of the study population was 35.1 ± 4.03 years: 43.6% (223/512) were below 35 years, 42.2% (216/512) were between 35 and 40 years, and 14.3% (73/512) over 40 years of age. The overall LBR was 34.3%. Cycle characteristics are presented in Table I , showing comparable baseline characteristics among study groups.
Univariate analysis
We found significant differences in LBRs (37.6% vs 27.3%; P = 0.01) between FET performed during Cycle 1 vs Cycle ≥2 (Table II) . The power of this analysis was 27.9%. Differences were not significant for IR ≥50% (43% vs 36.1%; P = 0.12), biochemical pregnancy (49.8% vs 43.8%; P = 0.17), clinical pregnancy (44.1% vs 36.1%; P = 0.07) or PL (11.8% vs 16.1%; P = 0.16).
A long agonist protocol was used for COH in 115 patients (22.5%) while a short antagonist protocol was used in the remaining 397 patients (77.5%). We observed no difference in LBR in the overall population between patients who underwent COH in a long agonist protocol (29.6%) vs a short antagonist protocol (33.5%; P = 0.43). The overall LBR was similar when comparing cycles in which ovulation was triggered with a GnRH agonist group when compared with the hCG group (35.7% vs 29.5%; P = 0.14). The difference remained not significant for LBR when endometrial preparation was performed with oral vs transdermal oestrogens (37% vs 28.8%; P = 0.05).
Multivariable analysis
A multivariable analysis was performed to adjust for potentially confounding factors and results are presented in Table III . The only variables that had a significant impact on LBR were maternal age, number of transferred embryos, day of embryonic development at transfer and type of oestrogen used.
Performing FET on the first vs subsequent menstrual cycles after OPU did not have a significant effect on any of the reproductive outcomes.
Discussion
We found no difference in LBR between FET performed during either the first menstrual cycle following OPU or during subsequent menstrual cycles, after a freeze-all strategy.
A growing body of evidence suggesting better IVF outcomes after a freeze-all policy has resulted in an increase in IVF cycles with elective embryo cryopreservation (Shapiro et al., 2014) , although PRs do not seem to be different in fresh ET vs FET (Zeadna et al., 2015) . It appears that most of the differences in outcomes between fresh ET and FET stem from the effect of COH on endometrial receptivity and embryo-endometrium synchrony (Weinerman and Mainigi, 2014) .
The negative impact of COH on endometrial gene expression and immune environment has been well documented (Mirkin et al., 2004; Horcajadas et al. 2005; Simon et al., 2005; Horcajadas et al. 2008; Liu et al. 2008; Haouzi et al. 2009; Chaouat, 2013; Junovich et al., 2011) . This translates into euploid embryos being less likely to implant and achieve a LBR in a fresh cycle than in a FET cycle (Rodriguez-Purata et al., 2016) . Unfortunately, there are no studies addressing how long it takes for the cyclic endometrium to recover its receptivity potential after COH and clinicians have no information on how long it is advisable to wait after OPU before performing an elective FET. This has led to delays in ET that may have a negative psychological impact on patients, adding up to the normal emotional stress associated with infertility and ART.
We found comparable implantation, pregnancy and CPRs although, in our population, the LBR-before adjustment by potentially confounding factors-was significantly higher in the Cycle 1 group (37.6% vs 27.3%), however the power of this analysis was 27.9% and, when controlling for potential confounders at multivariable analysis, this difference was not statistically significant. The PL rate did not differ among study groups (11.8% vs 16.1%). These results are comparable with available published data (Roque et al., 2015) . 
Table II
Results of the univariate analysis comparing FETs which took place either within the first menstrual cycle following OPU (Cycle 1) or afterwards (Cycle ≥2) after a freeze-all strategy. We found no impact of the stimulation protocol or ovulation trigger drug used in reproductive outcomes. In our opinion, these results show that the detrimental effect of ovarian hyperstimulation on endometrial receptivity ends, clinically, after the following withdrawal bleeding regardless of the stimulation protocol, ovulation trigger drug used, or endometrial preparation.
Our results indicate that transfer of the best available frozen-thawed embryos into a more physiologic endometrial environment can be performed as soon as the following cycle after OPU, optimizing reproductive outcomes while minimizing unnecessary delays in ET. This new information will allow clinicians to take patients' preferences into account when choosing the best moment to perform FET. This patient-oriented decision-making should be taken into consideration in modern medical practice as well as clinical research (Dancet et al., 2010 (Dancet et al., , 2011 (Dancet et al., , 2014 .
The primary limitation of our study is the uncontrolled potential for biases of the retrospective design. The distribution of cases between first and subsequent cycles is similar (51% vs 49%) and, in our centre, we do not have a clear policy on this. Therefore, it is unlikely that there was a selection bias in this regard. Although there were no significant differences in our results between groups, there was some heterogeneity among our patients in endometrial preparation for FET, which might have contributed to the observed results. It could be argued that the lack of significant effect on LBR of performing FET on subsequent menstrual cycles may be due to an underpowered analysis. However, the narrowness of the odds ratio (OR) CI (0.48-1.06) indicates that our study was powered enough to detect medium to large effect sizes. This is, to our knowledge, the first study to suggest that endometrial receptivity is restored after the first withdrawal bleeding after OPU and that performing FET during this first cycle is not associated with a negative impact in pregnancy and LBRs after a freeze-all strategy. Prospective, randomized, controlled studies are needed to confirm these results.
